I currently work at the Center for Vaccine Development, University of Maryland, Baltimore where work with a team to develop glycoconjugate vaccines against non-typhoidal Salmonella. Our most recent publication is 'Immunogenicity and protective efficacy against Salmonella C 2 -C 3 infection in mice immunized with a glycoconjugate of S. Newport Core-O polysaccharide linked to the homologous serovar FliC protein'.